共 50 条
The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19
被引:0
|作者:
Yildiz, Yesim
[1
]
Ozger, Hasan Selcuk
[1
]
Acar, Ali
[2
]
Seremet-Keskin, Aysegul
[3
]
Binay, Umut Devrim
[4
]
Unlu, Gulten
[5
]
Bayram, Halim
[6
]
Asan, Ali
[7
]
Akca, Mustafa Ozgur
[7
]
Karamanlioglu, Dilek
[8
]
Inan, Osman
[9
]
Kaya, Safak
[10
]
Yildirim, Cigdem
[11
]
Arslan, Yusuf
[12
]
Komur, Suheyla
[13
]
Saygideger, Yasemin
[14
]
Kandemir, Fatma Ozlem
[15
]
Yasar, Simge
[15
]
Akdemir-Kalkan, Irem
[16
]
Tekin-Tas, Zeynep
[17
]
Sakiz, Ayse
[18
]
Bayindir, Yasar
[19
]
Ozer, Ayse Belin
[20
]
Mete, Ayse Ozlem
[21
]
Erol, Cigdem
[22
]
Mermutluoglu, Cigdem
[23
]
Kadiroglu, Ali Kemal
[24
]
Azap, Alpay
[16
]
Senol, Esin
[1
]
机构:
[1] Gazi Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Ankara, Turkiye
[2] Atilim Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Ankara, Turkiye
[3] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Antalya, Turkiye
[4] Erzincan Binali Yildirim Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Erzincan, Turkiye
[5] Univ Hlth Sci, Kocaeli Derince Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Kocaeli, Turkiye
[6] Gaziantep Dr Ersin Arslan Tranining & Res Hosp, Dept Infect Dis & Clin Microbiol, Gaziantep, Turkiye
[7] Univ Hlth Sci, Bursa Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Bursa, Turkiye
[8] Ankara City Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkiye
[9] Ankara City Hosp, Dept Internal Med, Ankara, Turkiye
[10] Univ Hlth Sci, Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Diyarbakir, Turkiye
[11] Pursaklar State Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkiye
[12] Batman Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Batman, Turkiye
[13] Cukurova Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Adana, Turkiye
[14] Cukurova Univ, Dept Pulm, Sch Med, Adana, Turkiye
[15] Mersin Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Mersin, Turkiye
[16] Ankara Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Ankara, Turkiye
[17] Sincan Dr Nafiz Korez State Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkiye
[18] Mardin Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Mardin, Turkiye
[19] Inonu Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Malatya, Turkiye
[20] Inonu Univ, Dept Anesthesiol & Reanimat, Sch Med, Malatya, Turkiye
[21] Gaziantep Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Gaziantep, Turkiye
[22] Baskent Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Ankara, Turkiye
[23] Dicle Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Diyarbakir, Turkiye
[24] Dicle Univ, Dept Nephrol, Sch Med, Diyarbakir, Turkiye
来源:
关键词:
COVID-19;
vaccine;
intensive care unit;
risk factor;
SARS-CoV-2;
infection;
vaccine breakthrough infections;
variant of concerns;
D O I:
10.36519/idcm.2023.216
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
Objective: We aimed to investigate the vaccination status and the risk factors for the intensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpatients, divided into two groups as 'fully' and 'partially' vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mellitus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the predominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension (p=0.026), DM (p=0.048), and congestive heart failure (CHF) (p=0.005) were significantly higher in ICU patients and the median age was younger among non-ICU patients (p=0.033). Of patients, 16.9% (n=87) were fully vaccinated, and this group's need for ICU support was statistically significantly lower (p=0.021). Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vaccinated were associated with the need for ICU support. Therefore, all countries should continuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection.
引用
下载
收藏
页码:118 / 126
页数:9
相关论文